NASDAQ:ALGN - Align Technology Stock Price, News & Analysis

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) released its earnings results on Wednesday, July, 24th. The medical equipment provider reported $1.26 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.13 by $0.13. The medical equipment provider earned $600.70 million during the quarter, compared to analysts' expectations of $599.86 million. Align Technology had a return on equity of 29.26% and a net margin of 19.06%. The business's revenue was up 22.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.30 EPS. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for Align Technology.

Align Technology updated its third quarter earnings guidance on Wednesday, July, 24th. The company provided earnings per share (EPS) guidance of $1.09-1.16 for the period, compared to the Thomson Reuters consensus estimate of $1.45. The company issued revenue guidance of $585-600 million, compared to the consensus revenue estimate of $623.83 million.

13 brokers have issued 12 month price targets for Align Technology's stock. Their predictions range from $210.00 to $420.00. On average, they anticipate Align Technology's stock price to reach $294.40 in the next twelve months. This suggests a possible upside of 66.1% from the stock's current price. View Analyst Price Targets for Align Technology.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Align Technology.

Media coverage about ALGN stock has been trending negative on Saturday, according to InfoTrie. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Align Technology earned a media sentiment score of -2.3 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Align Technology.

Some companies that are related to Align Technology include Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN), RTI Surgical (RTIX), Invacare (IVC) and ConforMIS (CFMS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Adobe (ADBE), Micron Technology (MU), Paypal (PYPL), salesforce.com (CRM), Mastercard (MA), Visa (V) and Boeing (BA).

Align Technology's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.93%), BlackRock Inc. (8.90%), Private Advisor Group LLC (4.74%), Edgewood Management LLC (3.86%), Polen Capital Management LLC (3.26%) and Renaissance Technologies LLC (3.18%). Company insiders that own Align Technology stock include C Raymond Larkin Jr, Christopher C Puco, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler and Yuval Shaked. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Winslow Capital Management LLC, Price T Rowe Associates Inc. MD, Janus Henderson Group PLC, Janus Henderson Group PLC, BlackRock Inc., Bamco Inc. NY and Bank of New York Mellon Corp. Company insiders that have sold Align Technology company stock in the last year include C Raymond Larkin Jr, Christopher C Puco, Greg J Santora, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Warren S Thaler and Yuval Shaked. View Insider Buying and Selling for Align Technology.

ALGN stock was purchased by a variety of institutional investors in the last quarter, including Private Advisor Group LLC, Edgewood Management LLC, Nuveen Asset Management LLC, Invesco Ltd., Renaissance Technologies LLC, Man Group plc, Bessemer Group Inc. and Worldquant Millennium Advisors LLC. Company insiders that have bought Align Technology stock in the last two years include Joseph M Hogan and Vamsi Mohan Raj Pudipeddi. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $177.29.

Align Technology has a market capitalization of $14.16 billion and generates $1.97 billion in revenue each year. The medical equipment provider earns $400.23 million in net income (profit) each year or $4.92 on an earnings per share basis. Align Technology employs 11,660 workers across the globe.View Additional Information About Align Technology.

The official website for Align Technology is http://www.aligntech.com/.

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]